Nick Siddle, M.R.C.O.G.t:!: Philip Sarrel, M.D. Malcolm Whitehead, M.R.C.O.G. til

Size: px
Start display at page:

Download "Nick Siddle, M.R.C.O.G.t:!: Philip Sarrel, M.D. Malcolm Whitehead, M.R.C.O.G. til"

Transcription

1 FERTILITY AND STERILITY Copyright c 1987 The American Fertility Society Vol. 47, No.1, January 1987 Printed in U.8A. The effect of hysterectomy on the age at ovarian failure: identification of a subgroup of women with premature loss of ovarian function and literature review* Nick Siddle, M.R.C.O.G.t:!: Philip Sarrel, M.D. Malcolm Whitehead, M.R.C.O.G. til King's College School of Medicine and Dentistry, and Chelsea Hospital for Women, London, United Kingdom The age at ovarian failure was determined in 9 women who had previously undergone abdominal hysterectomy with bilateral ovarian conservation and in 226 women who had undergone a spontaneous menopause. The mean age of ovarian failure in the hysterectomized group was 45.4 ± 4. years (standard deviation), and this was significantly lower than the mean age of 49.5 ± 4.4 years in the nonhysterectomized control group (P <.1). There was a significant correlation between the age at hysterectomy and the age of ovarian failure in the women who were 44 years or less at the time of ovarian failure (r =.62, P <.1), implying a causal relationship. The indication for hysterectomy did not influence the time of ovarian failure. Two explanations are proposed as to how conventional surgery for hysterectomy may adversely affect ovarian function. Fertil Steril47:, 1986 In addition to suffering from the usual problems of ovarian failure, such as vasomotor instability and lower genital tract symptoms, women who undergo premature loss of ovarian function are at an increased risk of osteoporosis 1 and myocardial infarction. 2 Thus, ovarian conservation at the time of hysterectomy in women who are < 45 years of age is an accepted surgical practice. It is Received February 17, 1986; revised and accepted September 15, *Supported by a grant to M.I.W. from the Imperial Cancer Research Fund Laboratories, Lincoln's Inn Fields, London, United Kingdom. t Academic Department of Obstetrics and Gynaecology, King's College School of Medicine and Dentistry. thonorary Lecturer, Chelsea Hospital for Women. Visiting Senior Lecturer. Present address: Yale University School of Medicine, New Haven, Connecticut. /lreprint requests: Malcolm Whitehead, M.R.C.O.G., Senior Lecturer/Consultant, Academic Department of Obstetrics and Gynaecology, King's College School of Medicine and Dentistry, Denmark Hill, London SE5 8RX, United Kingdom. widely held that surgery for hysterectomy has no adverse effects upon the function of the conserved ovaries. This belief is based upon numerous studies performed during the past century that have reported that, after hysterectomy, the time of ovarian failure is not advanced However, careful examination of the medical literature reveals that although the majority of women continue to have normal ovarian function after hysterectomy, a substantial minority (and in some studies a majority) of hysterectomized women do indeed experience premature ovarian failure In the absence of neoplasia, most gynecologists discharge their patients from postoperative care 6 weeks after surgery. Patients who subsequently develop troublesome estrogen-deficiency symptoms may be referred back to the gynecologist but, in our experience, are often treated by the family physician or are referred to a menopause clinic. Thus, the gynecologist may be unaware of the true incidence of estrogen-deficiency symp- 94 Siddle et ai. Hysterectomy and ovarian failure Fertility and Sterility

2 . toms that follows hysterectomy. From experience in two large specialized menopause clinics, it was our impression that hysterectomy with ovarian conservation was associated with premature loss of ovarian function in some women. Therefore, we have reviewed our patients' case records. MATERIALS AND METHODS This retrospective study was performed in the Menopause Clinics at King's College Hospital and the Chelsea Hospital for Women. The case notes of 96 women who had attended either clinic with a variety of symptoms were appraised: 7 had undergone a spontaneous or "natural" menopause, and 26 had undergone hysterectomy. The patient was considered suitable for admission to this study only if she had never used exogenous estrogens and only if she had presented with at least 6 months' amenorrhea and with persistent symptoms such as vasomotor instability and/or vaginal dryness, which are unequivocally due to a lack of estrogen. Vasomotor instability was defined as hot flashes and/or night sweats sufficient to disturb the daily routine and/or sleep pattern. Vaginal dryness was defined as a complaint of a reduction in vaginal lubrication: in patients who were sexually active, this reduction had to be sufficient to require the use of a lubricant jelly or to render intercourse difficult. Clinical evidence of vaginal atrophy-thinning of the vaginal skin and alteration in color-also had to be present. In addition to these criteria, patients under the age of 47 years at presentation had to have plasma gonadotropin levels within the postmenopausal range for our laboratory. We chose this age because a previous epidemiologic study of the climacteric reported a mean age at menopause of 51.4 years with a standard deviation (SD) of Thus, patients under 47 years of age were more than 1 SD below the mean, and we required biochemical evidence of ovarian failure in this younger age group. In women undergoing a spontaneous menopause, the age at menopause was equated with the time of ovarian failure. In the hysterectomized subjects, the onset of persistent estrogendeficiency symptoms was equated with the time of ovarian failure. Hysterectomized women were admitted only if the abdominal route had been used and if the onset of symptoms had occurred after surgery; if both ovaries had been conserved Vol. 47, No, 1, January 1987 and if surgery had been performed for a nonmalignant condition. No patient had received pelvic radiotherapy. In patients undergoing surgery at either King's College or Chelsea Hospital, these criteria were validated by reference to the medical records; in patients who had undergone surgery at another hospital, these factors were validated either through correspondence with the family physician or with the surgeon. All patient ages and the interval between surgery and the onset of symptoms were recorded in completed years. Data from 229 women who had undergone a spontaneous menopause (henceforth termed the nonhysterectomized group), and from 9 women had undergone abdominal hysterectomy (the hysterectomized group) fulfilled our inclusion criteria. The most frequent reasons for excluding patients were previous use of exogenous estrogens, a lack of patient certainty regarding the age at onset of persistent symptoms, or a lack of documentation confirming that two apparently normal ovaries had been conserved at hysterectomy. In 71 of the 9 hysterectomized women, there was a single indication for hysterectomy and only one disease had been diagnosed histologically. In 19 women, there were multiple indications for hysterectomy, and/or more than one disease had been diagnosed by the pathologist-for example, co-existing fibroids and pelvic inflammatory disease. These 19 subjects were classified as having "multiple" indications. With one exception, all hysterectomized and nonhysterectomized subjects were white Europeans: the exception was an Asian who had undergone hysterectomy. Appropriate nonparametric analyses were performed because the data on age at menopause and age at ovarian failure were not normally distributed. AGE AT OVARIAN FAILURE RESULTS Figure 1 is a scattergram of the age at ovarian failure in the two groups. The age range in the nonhysterectomized women was 3 to 58 years (mean,49.5 ± 4.4 [SD] years). The age range for the hysterectomized group was 33 to 55 years (mean, 45.4 ± 4. years), and this was significantly lower than that of the nonhysterectomized group (Mann-Whitney test, P <.1). Siddle et a1. Hysterectomy and ovarian failure 95

3 AGE AT OVARIAN FAILURE NORMAL MENOPAUSE = Mean 49 S years n=229 p < 1 Mann - Whitney POST HYSTERECTOMY Mean = 45 4 years n 9 = ".... 3L- Figure 1 Scattergrams of the age at ovarian failure in 229 women who had undergone a spontaneous menopause and in 9 women after hysterectomy with bilateral ovarian conservation. RELATIONSHIPS BETWEEN AGE AT HYSTERECTOMY AND AGE AT OVARIAN FAILURE The interval between hysterectomy and age at ovarian failure is shown in Figure 2. In 31 patients (34%), ovarian failure.occurred within 2 years of surgery, whereas in some patients, as long as 15 years elapsed. Twenty of the 31 pa- tients experiencing ovarian failure within 2 years of surgery and 25 of 46 patients experiencing loss of ovarian function within 4 years of hysterectomy were < 45.4 years old when their symptoms developed. In total, 4 (44.4%) of the 9 hysterectomized patients had developed ovarian failure by age 45.4 years. These 4 patients were more than 1 SD below the mean age at ovarian failure for our nonhysterectomized group. The relationship between age at hysterectomy and age at ovarian failure was determined for the entire hysterectomy group: this was statistically significant (r =.6, P <.1). This relationship was investigated further by dividing the hysterectomized patients into two groups: those experiencing ovarian failure at age 44 years or less (33 patients) and those experiencing ovarian failure at age 45 years or more (57 patients). There was a statistically significant correlation (r =.62, P <.1) for the former (group 1, Figure 3), but no correlation was observed (r =.32, P >.5) for the latter (group 2, Fig. 3)_ RELATIONSHIPS BETWEEN INDICATION FOR HYSTERECTOMY AND AGE AT OVARIAN FAILURE We determined whether the disease process that resulted in symptoms necessitating hysterhysterectomy TO OVARIAN FAI LURE 58 Group 2 r a O 32 Age ;;, 45 at CMlrian failure.!! 53 I- Z UJ ti l/} 15 4 UJ a: a: :::l -.J u. o 45 "' 1 4 ::::> z z 45 :: o 8 34 Group 1 r= 62 p< OO1!i & 8 o 9 5 UJ 5 o 8 35 Age <45 at ovarian failure 32'----2L INTERVAL (years) Figure 2 The interval between hysterectomy and the onset of estrogendeficiency symptoms in 9 women. 96 Siddle et ai. Hysterectomy and ovarian failure AGE AT HYSTERECTOMY (Log scale) Figure 3 Relationships between age at ovarian failure and age at hysterectomy in 33 women developing estrogen-deficiency symptoms at age 44 years or less (group 1), and in 57 women developing symptoms at age 45 years or more (group 2). Fertility and Sterility

4 ... I:!!... I&J so II..., " a u... x.. Q:: 4.. l- oq I&J 3... p=ns Figure 4 Age at the time of ovarian failure for the various indications for surgery. ectomy might also be the cause of the earlier than expected ovarian failure. The age at the time of ovarian failure for the various indications for surgery is shown in Figure 4. These were compared with the use of nonparametric analysis of variance (Kruskal-Wallis test): there were no differences between the surgical groups. DISCUSSION Identification of the precise time of ovarian failure can be difficult if hysterectomy has been performed. Ovarian failure is a gradual process associated with fluctuations in steroidogenesis and, therefore, gonadotropin levels. We considered relying on the presence of elevated gonadotropin levels to make the diagnosis in both hysterectomized and nonhysterectomized women, but we believe this to be unreliable in retrospective analysis: ovarian failure may have occurred many months, if not years, prior to the time of gonadotropin estimation. In our younger women, we demanded the presence of elevated gonadotropin levels to confirm the diagnosis and to exclude other causes of secondary amenorrhea. Because it is generally accepted that the presence of persistent estrogen-deficiency symptoms indicates loss of significant ovarian function, we equated this with the time of ovarian failure in the hysterectomized subjects. Given the limitations of retrospective investigation, we believe that our criteria for diagnosing ovarian failure in this group are valid and that measuring age in completed years was sufficiently sensitive for the purposes of this study. In our opinion, the present data provide persuasive evidence that hysterectomy may advance the time of ovarian failure. The mean age at ovarian failure was significantly lower in the hysterectomized, as compared with the nonhysterectomized, group (Fig. 1, P <.1). However, it is also clear that not all women were equally affected by hysterectomy. Indeed, some women appear not to have been affected, and 44 patients did not experience symptoms of ovarian failure until at least 5 years had elapsed after surgery (Fig. 2). A subgroup of women appeared to suffer early loss of ovarian function, which was causally related to hysterectomy. Symptoms of ovarian failure arose in 31 patients within 2 years of hysterectomy and in 46 patients within 4 years of surgery. Importantly, 2 of the 31 patients, and 25 of the 46 patients, were < 45 years old when these symptoms arose. It is stressed that in total 4 (44.4%) ofthe 9 hysterectomized women had developed ovarian failure by age 45.4 years. In the nonhysterectomized group, only 29 (13%) of 229 women had experienced ovarian failure by this age (Fig. 1). Although our hysterectomized and nonhysterectomized groups were matched for race, reason for clinic referral, and lack of exposure to exogenous estrogens, it is possible that bias has occurred in patient selection. We did not control for cigarette use, but the lowering of age at menopause in tobacco users is small. I6 Even if heavy cigarette consumption occurred only in the hysterectomized women, we doubt very much whether this could explain the differences that we observed. It might be argued that women who undergo hysterectomy have certain physiologic characteristics that make them more likely to report ovarian failure earlier than women with an intact uterus: additionally, hysterectomized women, having previously been exposed to medical procedures, might be less frightened of a hospital environment and therefore request hospital referral more readily than nonhysterectomized women. Although we know of no data to support these arguments, they are clearly important sources of potential bias which we cannot completely eliminate. Furthermore, it might be argued that younger, symptomatic, hysterecto- Vol. 47, No.1, January 1987 Siddle et ai. Hysterectomy and ovarian failure 97

5 mized women might be preferentially referred because of physician bias. Again, we are not aware of any published data that demonstrate that the nonhysterectomized, symptomatic woman receives a less sympathetic response from her medical attendant than her hysterectomized counterpart. Physician bias of this nature could, perhaps, be best investigated by comparing age at referral to a clinic between hysterectomized and nonhysterectomized subjects with minimal symptoms insufficient to disturb well-being. We were not able to do this because all our subjects had symptoms sufficiently severe to reduce their quality of life prior to referral. Estimates of the time at ovarian failure differed between our groups. Six months' amenorrhea and the presence of persistent symptoms was the end point in the nonhysterectomized group, whereas the time of onset of persistent symptoms was the end point in the hysterectomized subjects. We considered using the onset of symptoms as the end point for comparisons, but believe this to be unreliable as a determinant of ovarian failure. In some women, the onset of vasomotor symptoms can predate the menopause by some years17: in our clinical experience, women in their early 4s with flashes and sweats experience them only premenstrually, not persistently. We believe our definitions to be the best compromise for timing of ovarian failure in a retrospective analysis. Despite these limitations, our finding that a subgroup of women developed ovarian failure at an early age following hysterectomy is supported by the medical literature. The major studies of ovarian function following hysterectomy published during the last 5 years from which numerical data can be extracted are shown in Table We have extracted the numbers of women with unilateral or bilateral ovarian conservation who were < 45 years at the time of operation, and the numbers subsequently developing ovarian failure according to the authors' criteria. These have varied from the presence of hot flashes alone to the use of vaginal smears, and most recently, biochemical methodology. In the majority of cases we have selected the figures relating to women with flashes. Because details of the time of assessment of individual women are only available in two papers, 11, 12 more detailed analyses are not possible. However, all the authors reported a subgroup of women with premature ovarian failure, the percentage ranging from 16.7%13 to 57.5%4 (mean, 23.5% ± 5.3%). Most authors ignored this subgroup: for example, Whitelaw,1 using measurements of urinary pregnanediol and a bioassay to determine gonadotropin activity, concluded that "continued ovarian activity is manifest in the majority of these subjects years after operation." However, "the majority" in this study means 18 of 24 women, because in the other 6 Table 1. Studies of Ovarian Function After Hysterectomy with B ilaterallu nilateral Ovarian Conservation Years of % Early' Criteria Authors No. of patients follow-up ovarian fbllure for failure Comment Sessums and Murphy, Flashes All < 36 years at time of 9323 operation Kretzschmar and Gard Flashes Retrospective questioniner, naire: unclear if unilateral or bilateral ovarian conservation Dippel, Flashes Mainly women who had cesarean hysterectomy Richards, Flashes All < 45 years old at time of operation Bancroft-Livingstone, Flashes All < 45 years old at time of operation Grogan and Duncan, 363 Up to Flashes Only one ovary conserved in some patients Randall et ai., Smears Whitelaw, Flashes and gonadotropins Leverton, Flashes and gonadotropins DeNeef and Hollenback, 115 Up to Flashes Beavis et ai., Urinary estrogens Ranney and Abu Flashes Data abstracted from au- Ghazaleh, thors' scattergrams Gath, Flashes 98 Siddle et ai. Hysterectomy and ovarian failure Fertility and Sterility

6 subjects the author stated "menopause was probably reached." Beavis et al.13 used symptomatic assessments and serial urinary estrogen and pregnanediol measurements as indicators of ovarian activity. They concluded that "ovarian function continued normally up to the time of the menopause." Our understanding of their data is that 16.7% of women experienced premature loss of ovarian function. Ranney and Abu-Ghazaleh14 relied solely on the presence of symptoms to assess ovarian function. Their study group was 1263 women. The authors concluded that "normal ovaries which are retained in vivo during hysterectomy will usually produce female hormones in each individual patient for the inherited duration of years." However, careful examination of the authors' scattergrams for the 59 women who were < 4 years old at the time of surgery indicates that 23% of this group experienced loss of ovarian function prematurely. The most recent prospective study of which we are aware is ongoing at Oxford and is an investigation of the psychiatric sequelae of hysterectomy. Professor Gath has kindly reviewed his data for us and reports the following among women under the age of 44 years at the time of hysterectomy in whom the ovaries were conserved18: within 6 months of surgery, 17.6% of the women were experiencing hot flashes and 24.3% had sweating. Eighteen months after operation, hot flashes were reported by 19.5% and sweating by 18.5% of patients. Four years after operation, 24.6% of women experienced hot flashes and 28.1 % had sweating; 25% of the women also reported vaginal dryness. Comparisons between the above studies are, we believe, inappropriate because of differences in study design, inclusion criteria, and length of follow-up. Nonetheless, it is clear that in each reported series some women have experienced premature ovarian failure following hysterectomy. Why should a subgroup of women develop ovarian failure at an early age after hysterectomy? If a disease had caused symptoms necessitating hysterectomy, and thereafter the ovarian failure, it would be expected that this disease would be associated with an increased incidence of earlier ovarian failure. However, this was not observed in this study: indeed, the age of ovarian failure was not related to the indication for surgery (Fig. 4). However, when the age at hysterectomy was Vol. 47, No.1, January 1987 compared with the age at ovarian failure, a significant correlation was observed for those women developing loss of ovarian function aged 44 years or below. This implies a causal relationship independent of the indication for surgery and not present if ovarian fail ure developed after age 45 (Fig. 3). How may hysterectomy affect ovarian function? It is possible that surgery compromises the vascular supply to the ovary. Alternatively, the uterus ay make an important endocrine contribution to normal ovarian function. The latter is unlikely to account for sudden ovarian failure, but the possibility that both mechanisms may operate to cause earlier than expected ovarian failure, even many years after surgery, cannot be excluded. In support of the first explanation, Stone et al.19 reported an acute drop in serum estradiol levels when hysterectomy was performed during the follicular phase of the cycle, from 6 pg/ml preoperatively to 2 pg/ml by the third postoperative day. No such reductions were observed in the control group of women undergoing laparoscopy. With the use of 133 Xenon clearance to measure ovarian blood flow immediately preoperatively and postoperatively, Janson and Jansson2 reported that surgery reduced blood flow by between 52% and 89%. Cattanach21 has recently reported a reduction in estrogen production in four of seven women after tubal ligation. He developed a hypothesis to explain how ligation of the medial uterine supply to the ovary might change intraarterial dynamics, increase intraarterial pressure, and damage the ovarian microcirculation, even if the lateral ovarian blood supply is not affected by surgery. The elegant studies of Sessums and Murphy22 have clearly demonstrated that the presence of uterine tissue is important for normal ovarian follicular development in rabbits. Animals that had undergone hysterectomy 12 months previously had only half the number of follicles, as compared with rabbits with intact uteri. However, rabbits that had undergone hysterectomy, but in which endometrium had been implanted into the anterior abdominal wall, had 4% more follicles than the hysterectomized group. Irrespective of the cause of the early ovarian failure, it is clear that hysterectomy increases the frequency of consultations for estrogen-deficiency symptoms. Roos23 compared the number of visits to a doctor by 2332 hysterectomized women and Siddle et ai. Hysterectomy and ovarian failure 99

7 2533 women after cholecystectomy. The number of visits in the hysterectomized group was 2.5 times greater than that following cholecystectomy, and Roos concluded "menopause symptoms increase after hysterectomy. Ageing alone contributed little to this increase since similar increases occurred in neither the cholecystectomy nor the population samples." We believe that we have demonstrated that hysterectomy may advance the time of ovarian failure in some women. However, with any menopause clinic sample of patients investigated retrospectively, it is impossible to eliminate every source of bias, and therefore we caution against extrapolating our incidence data to the general population. Because the consequences of early ovarian failure in terms of mortality and morbidity are considerable,1, 2 we believe that further prospective research is urgently needed to determine the incidence of early ovarian failure in the general population and also to elucidate the mechanisms involved. In the meantime, two practical approaches to patient management are suggested. The first is not to dismiss women as neurotic if they return soon after hysterectomy complaining of estrogen-deficiency symptoms. Under these circumstances, ovarian function should be properly assessed by gonadotropin measurements. The second is more speculative and is to avoid placing clamps close to the ovary during hysterectomy to minimize the risk of damaging the ovarian vascular arcade. Acknowledgments. The assistance of Mrs. Helen Kenna, Miss Frances Stewart, and Miss Julie Bennett in the preparation of the manuscript is much appreciated. REFERENCES 1. Johansson BW, Kaij L, Kullander S, Lenner H-C, Svanberg L, Astedt B: On some late effects of bilateral oophorectomy in the age range 15-3 years. Acta Obstet Gynecol Scand 54:449, Centerwall BS: Premenopausal hysterectomy and cardiovascular disease. Am J Obstet Gynecol 139:58, Sessums JV, Murphy DP: Hysterectomy and the artificial menopause. Surg Gynecol Obstet 55:286, Kretzschmar N, Gardiner S: A consideration of the surgical menopause after hysterectomy and the occurrence of cancer in the stump following subtotal hysterectomy. Am J Obstet Gynecol 29:168, Dippel AL: The role of hysterectomy in the production of menopausal symptoms. Am J Obstet Gynecol 37:111, Richards NA: The surgical menopause following hysterectomy: a study of 332 cases. Proc R Soc Med 44:496, Bancroft-Livingston G: Ovarian survival following hysterectomy. J Obstet Gynaecol Br Emp 61:628, Grogan RH, Duncan CJ: Ovarian salvage in routine abdominal hysterectomy. Am J Obstet Gynecol 7:1277, Randall CL, Birtch PK, Harkins JL: Ovarian function after the menopause. Am J Obstet Gynecol 74:719, Whitelaw RG: Ovarian activity following hysterectomy. J Obstet Gynecol Br Emp 65:917, Leverton JCS: Some aspects of ovarian conservation at hysterectomy for benign conditions. J Obstet Gynaecol Br Emp 65:839, DeNeef JC, Hollenback ZJR: The fate of ovaries preserved at the time of hysterectomy. Am J Obstet Gynecol 96: 188, Beavis ELG, Brown JB, Smith MA: Ovarian function af ter hysterectomy with conservation of the ovaries in premenopausal women. J Obstet Gynaecol Br Commonw 76: 969, Ranney B, Abu-Ghazaleh S: The future function and fortune of ovarian tissue which is retained in vivo during hysterectomy. Am J Obstet Gynecol 128:626, Benedek Jaszmann W: The epidemiology of the climacteric syndrome. In Management of the Menopause and Postmenopausal Years, Edited by S Campbell. Lancaster, MTP Press, 1976, p Kaufmann DW, Slone D, Rosenberg L, Miettinen OS, Shapiro S: Cigarette smoking and age at natural menopause. Am J Public Health 7:429, Bungay GT, Vessey MP, McPherson CK: Study of symptoms of middle life with special reference to the menopause. Br Med J 282:181, Gath C: Personal communication 19. Stone SC, Dickey RP, Mickal A: The acute effect of hysterectomy on ovarian function. Am J Obstet Gynecol 121:193, Janson PO, Jansson I: The acute effect of hysterectomy on ovarian blood flow. Am J Obstet Gynecol 127:349, Cattanach J: Oestrogen deficiency after tubal ligation. Lancet 1:847, Sessums JV, Murphy DP: The influence of endometrium upon the rabbit ovary after hysterectomy. Surg Gynecol Obstet 56:6, Roos NR: Hysterectomies in one Canadian province: a new look at riskslbenefits. Am J Public Health 74:39, Siddle et al. Hysterectomy and ovarian failure Fertility and Sterility

EVALUATION OF WOMEN FOLLOWING HYSTERECTOMY WITH AND WITHOUT CONSERVATION OF OVARIES

EVALUATION OF WOMEN FOLLOWING HYSTERECTOMY WITH AND WITHOUT CONSERVATION OF OVARIES Int. J. Chem. Sci.: 6(3), 2008, 1228-1235 EVALUATION OF WOMEN FOLLOWING HYSTERECTOMY WITH AND WITHOUT CONSERVATION OF OVARIES RAMPRASAD DEY, SUBHASH CHANDRA BISWAS, RANU ROY BISWAS a and ARUNIMA MUKHOPADHYAY

More information

25 mg oestradiol implants--the dosage of first choice for subcutaneous oestrogen replacement therapy?

25 mg oestradiol implants--the dosage of first choice for subcutaneous oestrogen replacement therapy? Research Subcutaneous estrogen replacement therapy. Jones SC. Journal of Reproductive Medicine March, 2004; 49(3):139-142. Department of Obstetrics and Gynecology, Keesler Medical Center, Keesler Air Force

More information

Menopause management NICE Implementation

Menopause management NICE Implementation Menopause management NICE Implementation Dr Paula Briggs Consultant in Sexual & Reproductive Health Southport and Ormskirk NHS Hospital Trust Why a NICE guideline (NG 23) Media reports about HRT have not

More information

Post-menopausal hormone replacement therapy. Evan Klass, MD May 17, 2018

Post-menopausal hormone replacement therapy. Evan Klass, MD May 17, 2018 Post-menopausal hormone replacement therapy Evan Klass, MD May 17, 2018 Are we really still talking about this? Are we really still talking about this? 1960-1975- estrogen prescriptions doubled. Pharma

More information

Learning Objectives. Peri menopause. Menopause Overview. Recommendation grading categories

Learning Objectives. Peri menopause. Menopause Overview. Recommendation grading categories Learning Objectives Identify common symptoms of the menopause transition Understand the risks and benefits of hormone replacement therapy (HRT) Be able to choose an appropriate hormone replacement regimen

More information

Hysterectomy with Preservation of both Ovaries does not Result in Premature Ovarian Failure

Hysterectomy with Preservation of both Ovaries does not Result in Premature Ovarian Failure The Journal of International Medical Research 2007; 35: 416 421 Hysterectomy with Preservation of both Ovaries does not Result in Premature Ovarian Failure V ATAY 1, T CEYHAN 2, İ BASER 2, S GUNGOR 2,

More information

Surgery to Reduce the Risk of Ovarian Cancer. Information for Women at Increased Risk

Surgery to Reduce the Risk of Ovarian Cancer. Information for Women at Increased Risk Surgery to Reduce the Risk of Ovarian Cancer Information for Women at Increased Risk Centre for Genetics Education NSW Health 2017 The Centre for Genetics Education NSW Health Level 5 2C Herbert St St

More information

The 6 th Scientific Meeting of the Asia Pacific Menopause Federation

The 6 th Scientific Meeting of the Asia Pacific Menopause Federation Predicting the menopause The menopause marks the end of ovarian follicular activity and is said to have occurred after 12 months amenorrhoea. The average age of the menopause is between 45 and 60 years

More information

06-Mar-17. Premature menopause. Menopause. Premature menopause. Menstrual cycle oestradiol. Premature menopause. Prevalence ~1% Higher incidence:

06-Mar-17. Premature menopause. Menopause. Premature menopause. Menstrual cycle oestradiol. Premature menopause. Prevalence ~1% Higher incidence: Menopause Dr Sonia Davison MBBS FRACP PhD Endocrinologist and Clinical Fellow, Jean Hailes for Women s Health Women s Health Research Program, Monash University = the last natural menstrual period depletion

More information

Hormone Treatments and the Risk of Breast Cancer

Hormone Treatments and the Risk of Breast Cancer Cornell University Program on Breast Cancer and Environmental Risk Factors in New York State (BCERF) Updated July 2002 Hormone Treatments and the Risk of Breast Cancer 1) Hormone Treatment After Menopause

More information

Hormones friend or foe? Undertreatment and quality of life. No conflicts of interest to declare

Hormones friend or foe? Undertreatment and quality of life. No conflicts of interest to declare Hormones friend or foe? Undertreatment and quality of life Anette Tønnes Pedersen MD, Ph.D. Consultant, Associate professor Dept. Of Gynecology / Fertility Clinic Rigshospitalet No conflicts of interest

More information

Orals,Transdermals, and Other Estrogens in the Perimenopause

Orals,Transdermals, and Other Estrogens in the Perimenopause Orals,Transdermals, and Other Estrogens in the Perimenopause Cases Denise Black, MD, FRCSC Assistant Professor, Obstetrics, Gynecology and Reproductive Sciences University of Manitoba 6/4/18 197 Faculty/Presenter

More information

Menopause & HRT. Matt McKenna Elliot Davis

Menopause & HRT. Matt McKenna Elliot Davis Menopause & HRT Matt McKenna Elliot Davis Menopause Before age 40: Premature Menopause After 12 months clinical diagnosis made Depletion of Ovarian Follicles Oestrogen Progesterone LH FSH Spontaneous Amemorrhoea

More information

improved with an MIS approach. This clinical benefit for American women has been demonstrated with Level I evidence. Hysterectomy is one of the most

improved with an MIS approach. This clinical benefit for American women has been demonstrated with Level I evidence. Hysterectomy is one of the most Statement of the Society of Gynecologic Oncology to the Food and Drug Administration s Obstetrics and Gynecology Medical Devices Advisory Committee Concerning Safety of Laparoscopic Power Morcellation

More information

Menopause Symptoms and Management: After Breast Cancer

Menopause Symptoms and Management: After Breast Cancer Menopause Symptoms and Management: After Breast Cancer An Educational Webinar for Patients and their Caregivers Wen Shen, MD, MPH Division of Gynecologic Specialties July 27, 2018 1 Disclosure I have a

More information

CASE 4- Toy et al. CASE FILES: Obstetrics & Gynecology

CASE 4- Toy et al. CASE FILES: Obstetrics & Gynecology CASE 4- Toy et al. CASE FILES: Obstetrics & Gynecology A 49-year-old woman complains of irregular menses over the past 6 months, feelings of inadequacy, vaginal dryness, difficulty sleeping, and episodes

More information

Southern California Center for Sexual Health and Survivorship Medicine Inc, Newport Beach, CA 3

Southern California Center for Sexual Health and Survivorship Medicine Inc, Newport Beach, CA 3 The WISDOM survey: Physicians Level of Comfort Prescribing Treatment for Vulvar and Vaginal Atrophy (VVA) Symptoms in Women with a Predisposition or History of Breast Cancer Lisa Larkin, MD 1 ; Michael

More information

The 6 th Scientific Meeting of the Asia Pacific Menopause Federation

The 6 th Scientific Meeting of the Asia Pacific Menopause Federation Abnormal uterine bleeding in the perimenopause Perimenopausal menstrual problems are among the most common causes for family practitioner and specialist referral. Often it is due to the hormone changes

More information

Audit changes clinical practice! impact on rate of justification of hysterectomy indication

Audit changes clinical practice! impact on rate of justification of hysterectomy indication ecommons@aku Department of Obstetrics & Gynaecology Division of Woman and Child Health August 1995 Audit changes clinical practice! impact on rate of justification of hysterectomy indication Khalid S.

More information

Two-thirds of the almost one-half million

Two-thirds of the almost one-half million Minimally Invasive Surgery New data and the guidance of our professional societies are bringing us closer to clarity in understanding the superiority of minimally invasive techniques of hysterectomy Amy

More information

A Prospective Observational Study to Evaluate the Efficacy and Safety Profiles of Leuprorelin 3 Month Depot for the Treatment of Pelvic Endometriosis

A Prospective Observational Study to Evaluate the Efficacy and Safety Profiles of Leuprorelin 3 Month Depot for the Treatment of Pelvic Endometriosis SH SUEN & SCS CHAN A Prospective Observational Study to Evaluate the Efficacy and Safety Profiles of Leuprorelin 3 Month Depot for the Treatment of Pelvic Endometriosis Sik Hung SUEN MBChB, MRCOG Resident

More information

Hysterectomy : A Clinicopathologic Correlation

Hysterectomy : A Clinicopathologic Correlation Bahrain Medical Bulletin, Vol. 28, No.2, June 2006 Hysterectomy : A Clinicopathologic Correlation Layla S Abdullah, FRCPC* Objective : To study the most common pathologies identified in hysterectomy specimens

More information

PERIMENOPAUSE. Objectives. Disclosure. The Perimenopause Perimenopause Menopause. Definitions of Menopausal Transition: STRAW.

PERIMENOPAUSE. Objectives. Disclosure. The Perimenopause Perimenopause Menopause. Definitions of Menopausal Transition: STRAW. PERIMENOPAUSE Patricia J. Sulak, MD Founder, Living WELL Aware LLC Author, Should I Fire My Doctor? Author, Living WELL Aware: Eleven Essential Elements to Health and Happiness Endowed Professor Texas

More information

X-Plain Ovarian Cancer Reference Summary

X-Plain Ovarian Cancer Reference Summary X-Plain Ovarian Cancer Reference Summary Introduction Ovarian cancer is fairly rare. Ovarian cancer usually occurs in women who are over 50 years old and it may sometimes be hereditary. This reference

More information

Menopause: diagnosis and management NICE guideline NG23. Published November 2015

Menopause: diagnosis and management NICE guideline NG23. Published November 2015 Menopause: diagnosis and management NICE guideline NG23 Published November 2015 1 Full title: Menopause : diagnosis and management Available at: http://www.nice.org.uk/guidance/ng23 Guideline published

More information

Menopause and Cancer risk; What to do overcome the risks? Fatih DURMUŞOĞLU,M.D

Menopause and Cancer risk; What to do overcome the risks? Fatih DURMUŞOĞLU,M.D Menopause and Cancer risk; What to do overcome the risks? Fatih DURMUŞOĞLU,M.D Menopause and Cancer How does menopause affect a woman s cancer risk? Ø Menopause does not cause cancer.but risk of developing

More information

Consent Advice No. XX (Joint with BSGE) Peer Review Draft Spring Morcellation for Laparoscopic Myomectomy or Hysterectomy

Consent Advice No. XX (Joint with BSGE) Peer Review Draft Spring Morcellation for Laparoscopic Myomectomy or Hysterectomy 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 Consent Advice No. XX (Joint with BSGE) Peer Review Draft

More information

Use of Ovarian Suppression and Ablation in Breast Cancer Treatment

Use of Ovarian Suppression and Ablation in Breast Cancer Treatment Use of Ovarian Suppression and Ablation in Breast Cancer Treatment Dr Marina Parton Consultant Medical Oncologist Royal Marsden and Kingston Hospitals Overview Breast cancer phenotypes Use of ovarian manipulation

More information

North American Menopause Society (NAMS)

North American Menopause Society (NAMS) North American Menopause Society (NAMS) 2012 Hormone Therapy Position Statement Cynthia B. Evans, MD Assistant Professor-Clinical Department of Obstetrics and Gynecology The Ohio State University College

More information

University Gynecologic Oncology Associates

University Gynecologic Oncology Associates University Gynecologic Oncology Associates Medical History Form Date: Name: Date of Birth: / / GYNE HISTORY Age of first period? If you no longer have periods, at what age did they stop? Are you pregnant

More information

Hysterectomy. What is a hysterectomy? Why is hysterectomy done? Are there alternatives to hysterectomy?

Hysterectomy. What is a hysterectomy? Why is hysterectomy done? Are there alternatives to hysterectomy? 301.681.3400 OBGYNCWC.COM What is a hysterectomy? Hysterectomy Hysterectomy is surgery to remove the uterus. It is a very common type of surgery for women in the United States. Removing your uterus means

More information

Hormonal Changes Following Low-Dosage Irradiation of Pituitary and Ovaries in Anovulatory Women

Hormonal Changes Following Low-Dosage Irradiation of Pituitary and Ovaries in Anovulatory Women Hormonal Changes Following Low-Dosage Irradiation of Pituitary and Ovaries in Anovulatory Women Further Studies A. E. Rakoff, M.D. Tms PRESENTATION is a second progress report in a long-term study of the

More information

CY Tse, AMK Chow, SCS Chan. Introduction

CY Tse, AMK Chow, SCS Chan. Introduction Effects of an extended-interval dosing regimen of triptorelin depot on the hormonal profile of patients with endometriosis: prospective observational study CY Tse, AMK Chow, SCS Chan Objective. To evaluate

More information

Minimal Access Surgery in Gynaecology

Minimal Access Surgery in Gynaecology Gynaecology & Fertility Information for GPs August 2014 Minimal Access Surgery in Gynaecology Today, laparoscopy is an alternative technique for carrying out many operations that have traditionally required

More information

Work Loss Associated With Increased Menstrual Loss in the United States

Work Loss Associated With Increased Menstrual Loss in the United States Work Loss Associated With Increased Menstrual Loss in the United States Isabelle Côté, PhD, Philip Jacobs, DPhil, CMA, and David Cumming, MBChB OBJECTIVE: To estimate the effect of increased menstrual

More information

Endometrial Cancer Biopsy of the endometrium Evaluation of women of all ages

Endometrial Cancer Biopsy of the endometrium Evaluation of women of all ages Endometrial Cancer Biopsy of the endometrium Evaluation of women of all ages Barbara S. Apgar, MD, MS Professor of Family Medicine University of Michigan Health System Ann Arbor, Michigan Cancer of the

More information

Hormonal Control of Human Reproduction

Hormonal Control of Human Reproduction Hormonal Control of Human Reproduction Bởi: OpenStaxCollege The human male and female reproductive cycles are controlled by the interaction of hormones from the hypothalamus and anterior pituitary with

More information

Leslie R. Schover, PhD Department of Behavioral Science

Leslie R. Schover, PhD Department of Behavioral Science Causes and Treatments of Low Sexual Desire in Breast Cancer Survivors Leslie R. Schover, PhD Department of Behavioral Science IMPORTANCE OF SEX TO BREAST CANCER SURVIVORS Livestrong 2006 Post-Treatment

More information

Clinical Efficacy and Complications of Uterine Artery Embolization in Symptomatic Uterine Fibroids

Clinical Efficacy and Complications of Uterine Artery Embolization in Symptomatic Uterine Fibroids Global Journal of Health Science; Vol. 8, No. 7; 2016 ISSN 1916-9736 E-ISSN 1916-9744 Published by Canadian Center of Science and Education Clinical Efficacy and Complications of Uterine Artery Embolization

More information

Endometriosis of the Appendix Resulting in Perforated Appendicitis

Endometriosis of the Appendix Resulting in Perforated Appendicitis 27 Endometriosis of the Appendix Resulting in Perforated Appendicitis Toru Hasegawa a Koichi Yoshida b Kazuhiro Matsui c a Department of Obstetrics and Gynecology, Faculty of Medicine, University of Toyama,

More information

The Estrogen Question

The Estrogen Question The Estrogen Question Hormone Therapy still offers the best relief for menopausal symptoms. Is it right for you? When 49-year-old Lee Ann Dodson heard the news that the Women's Health Initiative (WHI)

More information

Year: Issue 1 Obs/Gyne The silent epidemic: Postmenopausal vaginal atrophy

Year: Issue 1 Obs/Gyne The silent epidemic: Postmenopausal vaginal atrophy Year: 2013 - Issue 1 Obs/Gyne The silent epidemic: Postmenopausal vaginal atrophy By: Dr David W Sturdee, Immediate past President International Menopause Society and Hon Consultant Gynaecologist, Solihull

More information

Summary of the risk management plan (RMP) for Duavive (conjugated oestrogens / bazedoxifene)

Summary of the risk management plan (RMP) for Duavive (conjugated oestrogens / bazedoxifene) EMA/679870/2014 Summary of the risk management plan (RMP) for Duavive (conjugated oestrogens / bazedoxifene) This is a summary of the risk management plan (RMP) for Duavive, which details the measures

More information

Cervical Cancer - Suspected

Cervical Cancer - Suspected Cervical Cancer - Suspected Presentation for patients Asymptomatic presentation Symptomatic presentation History and examination Consider differential diagnoses RED FLAG! Cervix appears normal after examination

More information

Premature Menopause : Diagnosis and Management

Premature Menopause : Diagnosis and Management Guideline Number 3 : August 2010 Premature Menopause : Diagnosis and Management Introduction : Premature menopause is a serious condition that affects young women and remains an enigma. The challenges

More information

me LUTEINIZED UNRUPTURED FOLLICLE SYNDROME AND ENDOMETRIOSIS

me LUTEINIZED UNRUPTURED FOLLICLE SYNDROME AND ENDOMETRIOSIS FERTILITY AND STERILITY Copyright c 980 The American Fertility Society Vol. 33,, JanuaEY 980 Printed in U.S.A. me LUTEINIZED UNRUPTURED FOLLICLE SYNDROME AND ENDOMETRIOSIS W. PAULDMOWSKI, M.D.,.PH.D.*

More information

FERTILITY & TCM. On line course provided by. Taught by Clara Cohen

FERTILITY & TCM. On line course provided by. Taught by Clara Cohen FERTILITY & TCM On line course provided by Taught by Clara Cohen FERTILITY & TCM FERTILITY AND TCM THE PRACTITIONER S ROLE CAUSES OF INFERTILITY RISK FACTORS OBJECTIVES UNDERSTANDING TESTS Conception in

More information

Female Patient Questionnaire & History

Female Patient Questionnaire & History !! Female Patient Questionnaire & History Name: Today s Date: (Last) (First) (Middle) Date of Birth: Age: Weight: Occupation: Home Address: City: State: Zip: Home Phone: Cell Phone: Work: E-Mail Address:

More information

Gynaecological cancers. Mr Vivek Nama MD MRCOG Consultant Gynaecological Oncologist

Gynaecological cancers. Mr Vivek Nama MD MRCOG Consultant Gynaecological Oncologist Gynaecological cancers Mr Vivek Nama MD MRCOG Consultant Gynaecological Oncologist Gynaecological cancers Why do we need 2 week wait? Early/timely diagnosis of cancer Possibly less invasive treatment and

More information

A survey on the histopathologic findings in 636 cases of hysterectomy: A sonographic assessment study

A survey on the histopathologic findings in 636 cases of hysterectomy: A sonographic assessment study Available online at http://www.ijabbr.com International journal of Advanced Biological and Biomedical Research Volume 1, Issue 11, 2013: 1471-1477 A survey on the histopathologic findings in 636 cases

More information

Female Patient Questionnaire & History

Female Patient Questionnaire & History Female Patient Questionnaire & History Name: (Last) (First) (Middle) Today s Date: Home Phone: Cell Phone: Work: E-Mail Address: Primary Care Physician s Name: May we contact you via E-Mail? ( ) YES (

More information

Life stress and hysterectomy-oophorectomy

Life stress and hysterectomy-oophorectomy Maturitas, 6 (1984) 319-325 Elsevier 319 MAT 00323 Life stress and hysterectomy-oophorectomy loor W. Kraaimaat and Arend T. Veeninga Academic Hospital, Utrecht, The Netherlands (Received 18 April 1984;

More information

Both type I and type II tumors develop from extraovarian tissue that implants on the ovary. Both for LGSC and HGSC, the fallopian tube appears to be

Both type I and type II tumors develop from extraovarian tissue that implants on the ovary. Both for LGSC and HGSC, the fallopian tube appears to be Recent studies have led to the development of a new paradigm for the pathogenesis and origin of EOC, based on a dualistic model of carcinogenesis that divides EOC into 2 broad categories designated types

More information

Long Term Toxicity of Endocrine Therapy for premenopausal women with ER positive breast cancer

Long Term Toxicity of Endocrine Therapy for premenopausal women with ER positive breast cancer Global Breast Cancer Conference 2017 21 st Apr, 2017@Chezu Island Long Term Toxicity of Endocrine Therapy for premenopausal women with ER positive breast cancer Shinji Ohno, M.D., Ph.D., F.A.C.S. Breast

More information

Reproduction and Development. Female Reproductive System

Reproduction and Development. Female Reproductive System Reproduction and Development Female Reproductive System Outcomes 5. Identify the structures in the human female reproductive system and describe their functions. Ovaries, Fallopian tubes, Uterus, Endometrium,

More information

Infertility: failure to conceive within one year of unprotected regular sexual intercourse. Primary secondary

Infertility: failure to conceive within one year of unprotected regular sexual intercourse. Primary secondary Subfertility Infertility: failure to conceive within one year of unprotected regular sexual intercourse. Primary secondary Infertility affects about 15 % of couples. age of the female. Other factors that

More information

The Centre for Reproductive Medicine HYSTERECTOMY

The Centre for Reproductive Medicine HYSTERECTOMY The Centre for Reproductive Medicine PO Box 20559 Nimbin NSW 2480 Australia Maxwell Brinsmead MB BS PhD MRCOG FRANZCOG Phone + 61 409 870 346 Retired Obstetrician & Gynaecologist E-mail max@brinsmead.net.au

More information

Hysterectomy Fact versus fiction. Richard Dover Specialist Gynaecologist

Hysterectomy Fact versus fiction. Richard Dover Specialist Gynaecologist Hysterectomy Fact versus fiction Richard Dover Specialist Gynaecologist Disclaimer Disclaimer Hysterectomy An update? Myths busted? HYSTERECTOMY Retro-chic! HMB Important cause of morbidity Affects

More information

Correlates of Hysterectomy among African-American Women

Correlates of Hysterectomy among African-American Women American Journal of Epidemiology Copyright O 99 by The Johns Hopkins University School of Hygiene and Public Health All rights reserved Vol. 150, Printed In USA. Correlates of Hysterectomy among African-American

More information

bleeding Studies naar de diagnostiek van endom triumcarcinoom bij vrouwen met postm nopauzaal bloedverlies. Studies on the

bleeding Studies naar de diagnostiek van endom triumcarcinoom bij vrouwen met postm nopauzaal bloedverlies. Studies on the Studies on the diagnosis of endometria cancer in women with postmenopausal bleeding. Studies naar de diagnostiek va endometriumcarcinoom bij vrouwen m postmenopauzaal bloedverlies. Studies on the diagnosis

More information

Prior disclosures past 3 years Consultant for Pfizer University of Virginia received Grants/research support from TherapeuticsMD

Prior disclosures past 3 years Consultant for Pfizer University of Virginia received Grants/research support from TherapeuticsMD Prior disclosures past 3 years Consultant for Pfizer University of Virginia received Grants/research support from TherapeuticsMD JoAnn V. Pinkerton, MD Professor of Obstetrics and Gynecology Director,

More information

Research. Breast cancer represents a major

Research. Breast cancer represents a major Research GENERAL GYNECOLOGY Gynecologic conditions in participants in the NSABP breast cancer prevention study of tamoxifen and raloxifene (STAR) Carolyn D. Runowicz, MD; Joseph P. Costantino, DrPH; D.

More information

LUTEINIZED UNRUPTURED FOLLICLE SYNDROME: A SUBTLE CAUSE OF INFERTILITY*

LUTEINIZED UNRUPTURED FOLLICLE SYNDROME: A SUBTLE CAUSE OF INFERTILITY* FERTILITY AND STERILITY Copyright c 1978 The American Fertility Society Vol. 29, No.3, March 1978 Printed in U.S.A. LUTEINIZED UNRUPTURED FOLLICLE SYNDROME: A SUBTLE CAUSE OF INFERTILITY* JAROSLA V MARIK,

More information

Menopause and HRT. John Smiddy and Alistair Ledsam

Menopause and HRT. John Smiddy and Alistair Ledsam Menopause and HRT John Smiddy and Alistair Ledsam Menopause The cessation of menstruation Diagnosed retrospectively after 1 year of amenorrhoea Average age 51 in the UK Normal physiology - Menstruation

More information

ABSTRACT. KEY WORDS antibiotics; prophylaxis; hysterectomy

ABSTRACT. KEY WORDS antibiotics; prophylaxis; hysterectomy Infectious Diseases in Obstetrics and Gynecology 8:230-234 (2000) (C) 2000 Wiley-Liss, Inc. Wound Infection in Gynecologic Surgery Aparna A. Kamat,* Leo Brancazio, and Mark Gibson Department of Obstetrics

More information

HYSTERECTOMY FOR BENIGN CONDITIONS

HYSTERECTOMY FOR BENIGN CONDITIONS HYSTERECTOMY FOR BENIGN CONDITIONS UnitedHealthcare Oxford Clinical Policy Policy Number: SURGERY 104.7 T2 Effective Date: April 1, 2018 Table of Contents Page INSTRUCTIONS FOR USE... 1 CONDITIONS OF COVERAGE...

More information

Primary and secondary amenorrhoea

Primary and secondary amenorrhoea BRITISH MEDICAL JOURNAL VOLUME 294 28 MARCH 1987 815 Clinical Aalgorithms Primary and secondary amenorrhoea S FRANKS Amenorrhoea, which is usually defined as no periods for six months or more, occurs in

More information

Histopathological Study of Hysterectomy Operations in A University Clinic in Tehran From 2005 to 2009

Histopathological Study of Hysterectomy Operations in A University Clinic in Tehran From 2005 to 2009 Histopathological Study of Hysterectomy Operations in A University Clinic in Tehran From 2005 to 2009 Mahmoud Khaniki; M.D. 1, Mahsa Shojaie; M.D. 2, Azam M Tarafdari; M.D. 3 1 Department of Pathology,

More information

Management of Patients With Premature Ovarian Insufficiency

Management of Patients With Premature Ovarian Insufficiency Management of Patients With Premature Ovarian Insufficiency Prof. Dr. H. Cavidan Gülerman Sağlık Bilimleri Üniversitesi Ankara Dr. Zekai Tahir Burak SUAM XII. Türk Alman Jinekoloji Kongresi 28 Nisan 2018

More information

Ohio Northern University HealthWise. Authors: Alexis Dolin, Andrew Duska, Hannah Lamb, Eric Miller, Pharm D Candidates 2018 May 2018

Ohio Northern University HealthWise. Authors: Alexis Dolin, Andrew Duska, Hannah Lamb, Eric Miller, Pharm D Candidates 2018 May 2018 Women s Health Authors: Alexis Dolin, Andrew Duska, Hannah Lamb, Eric Miller, Pharm D Candidates 2018 May 2018 Let Your Body Empower You! National Women s Health Week Polycystic Ovary Syndrome Page 2 Breast

More information

Subtotal Versus Total Abdominal Hysterectomy

Subtotal Versus Total Abdominal Hysterectomy Bahrain Medical Bulletin, Vol.23, No.3, September 2001 Subtotal Versus Total Abdominal Hysterectomy Hassan Jamal, MD, CABOG* Z Amarin, MD, MSc, FRCOG** Objectives: To study subtotal compared to total hysterectomy.

More information

Research Article The Treatment with Hormone Replacement Therapy and Phytoestrogens and The Evolution of Urogenital Symptoms in Postmenopausal Women

Research Article The Treatment with Hormone Replacement Therapy and Phytoestrogens and The Evolution of Urogenital Symptoms in Postmenopausal Women Cronicon OPEN ACCESS PHARMACEUTICAL SCIENCE Research Article The Treatment with Hormone Replacement Therapy and Phytoestrogens and The Evolution of Urogenital Symptoms Bungau S 1, Tit DM 1 *, Fodor K 1

More information

Menstrual Disorders & Ambulatory Gynaecology

Menstrual Disorders & Ambulatory Gynaecology Menstrual Disorders & Ambulatory Gynaecology Mr. Nagui Lewis Aziz M B, CH B, FRCOG Consultant Gynaecologist The Royal Oldham Hospital 01/09/2018 Heavy menstrual bleeding (HMB ) is a common problem responsible

More information

Kimberley A. Schroeder, D.O. 115 Baker Drive Tomball, TX

Kimberley A. Schroeder, D.O. 115 Baker Drive Tomball, TX Kimberley A. Schroeder, D.O. 115 Baker Drive Tomball, TX 77375 281.290.0531 www.feelwellagain.com FEMALE MEDICAL QUESTIONNAIRE (POSTMENOPAUSAL) NAME: DATE OF BIRTH: CHIEF COMPLAINT What is your primary

More information

Menopause 101. Sharzad Green, Pharm.D. Community Clinical Pharmacy

Menopause 101. Sharzad Green, Pharm.D. Community Clinical Pharmacy Menopause 101 Sharzad Green, Pharm.D. Community Clinical Pharmacy 1 She has such different moods. One day she is all smiles and happiness. Other days there is no living with her. Throughout a woman s life,

More information

What You Need to Know About Ovarian Cancer

What You Need to Know About Ovarian Cancer What You Need to Know About Ovarian Cancer About Us The Rhode Island Ovarian Cancer Alliance (RIOCA) was formed in honor and memory of Jessica Morris. Jessica was diagnosed with Stage IIIC Ovarian Cancer

More information

Interventions to Address Sexual Problems in People with Cancer

Interventions to Address Sexual Problems in People with Cancer A Quality Initiative of the Program in Evidence-Based Care (PEBC), Cancer Care Ontario (CCO) Interventions to Address Sexual Problems in People with Cancer L. Barbera, C. Zwaal, D. Elterman, K. McPherson,

More information

One of the commonest gynecological cancers,especially in white Americans.

One of the commonest gynecological cancers,especially in white Americans. Gynaecology Dr. Rozhan Lecture 6 CARCINOMA OF THE ENDOMETRIUM One of the commonest gynecological cancers,especially in white Americans. It is a disease of postmenopausal women with a peak incidence in

More information

Core Module 13: Gynaecological Problems

Core Module 13: Gynaecological Problems Core Module 13: Gynaecological Problems Learning outcomes: To understand and demonstrate appropriate knowledge, skills and attitudes in relation to common gynaecological disorders To understand paediatric

More information

Ovarian Remnant Syndrome

Ovarian Remnant Syndrome Ovarian Remnant Syndrome Dawna L. Voelkl, DVM, Dipl ACT University of Missouri College of Veterinary Medicine Ovarian Remnant Syndrome Definition Incidence Clinically applicable anatomy and etiology Clinical

More information

Postmenopausal hormone therapy and cancer risk

Postmenopausal hormone therapy and cancer risk International Congress Series 1279 (2005) 133 140 www.ics-elsevier.com Postmenopausal hormone therapy and cancer risk P. Kenemans*, R.A. Verstraeten, R.H.M. Verheijen Department of Obstetrics and Gynaecology,

More information

US Imaging of pelvic congestion syndrome

US Imaging of pelvic congestion syndrome US Imaging of pelvic congestion syndrome Poster No.: C-1210 Congress: ECR 2015 Type: Educational Exhibit Authors: D. S. Baviskar, S. Baviskar; Abu Dhabi/AE Keywords: Pelvis, Vascular, Veins / Vena cava,

More information

JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH

JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH How to cite this article: CHOWTA N K,SEBASTIAN J,CHOWTA M N.COMPARATIVE STUDY OF MENOPAUSAL SYMPTOMS IN POST MENOPAUSAL AND PERIMENOPAUSAL WOMEN.Journal of Clinical

More information

SOFTly: The Long Natural History of [Trials for] [premenopausal] ER+ Breast Cancer

SOFTly: The Long Natural History of [Trials for] [premenopausal] ER+ Breast Cancer SOFTly: The Long Natural History of [Trials for] [premenopausal] ER+ Breast Cancer Charles Moertel Lecture May 12, 2017 Gini Fleming Charles Moertel Founder of NCCTG Dedication to high quality clinical

More information

Knowledge and Perception of Menopause and Climacteric Symptoms among a Population of Women in Enugu, South East, Nigeria

Knowledge and Perception of Menopause and Climacteric Symptoms among a Population of Women in Enugu, South East, Nigeria Annals of Medical and Health Sciences Research January 211 Vol. 1 N.1 Knowledge and Perception of Menopause and Climacteric Symptoms among a Population of Women in Enugu, South East, Nigeria Ikeme ACC*,

More information

One Day Hormone Check

One Day Hormone Check One Day Hormone Check DOB: Sex: F MRN: Order Number: Completed: Received: Collected: Salivary Hormone Results Estradiol pmol/l >3330.0 Testosterone pmol/l

More information

Managing menopause in Primary Care and recent advances in HRT

Managing menopause in Primary Care and recent advances in HRT Managing menopause in Primary Care and recent advances in HRT Raj Saha, MD, DMRT, FRCOG PG Cert. Advanced Gynaecology Endoscopy Consultant Gynaecologist Heart of England NHS Foundation Trust Spire Parkway

More information

Molly A. Brewer DVM, MD, MS Chair and Professor Department of Obstetrics and Gynecology University of Connecticut School of Medicine

Molly A. Brewer DVM, MD, MS Chair and Professor Department of Obstetrics and Gynecology University of Connecticut School of Medicine Molly A. Brewer DVM, MD, MS Chair and Professor Department of Obstetrics and Gynecology University of Connecticut School of Medicine Review causes of abnormal uterine bleeding: Adolescent Reproductive

More information

Patient Health Forms

Patient Health Forms Patient Health Forms All forms MUST be completed and signed prior to seeing the Provider First: M: Last: Email Address: Home Address: Best Phone Number to Reach You: Last 4 of your social security #: Marital

More information

Register No: Status: Public

Register No: Status: Public MANAGEMENT OF MENOPAUSE CLINICAL GUIDELINES Register No: 18009 Status: Public Developed in response to: RCOG guideline: Best Practice 2015 Contributes to CQC 11, 12 Consulted With Post/Committee/Group

More information

INSURANCE DISCLAIMER

INSURANCE DISCLAIMER INSURANCE DISCLAIMER Preventative medicine and bio- identical hormone replacement is a unique practice and is considered a form of alternative medicine. Even though the physicians and nurses are board

More information

Preservation of the ovary: a reevaluation

Preservation of the ovary: a reevaluation FERTIUTY AND STERILITY Copyright e 1984 The American Fertility Society Printed in U.s A. Preservation of the ovary: a reevaluation Celso-Ram6n Garcia, M.D. *t Winnifred Berg Cutler, Ph.D.t Department of

More information

9.4 Regulating the Reproductive System

9.4 Regulating the Reproductive System 9.4 Regulating the Reproductive System The Reproductive System to unite a single reproductive cell from a female with a single reproductive cell from a male Both male and female reproductive systems include

More information

Gynecologic Cancers are many diseases. Gynecologic Cancers in the Age of Precision Medicine Advances in Internal Medicine. Speaker Disclosure:

Gynecologic Cancers are many diseases. Gynecologic Cancers in the Age of Precision Medicine Advances in Internal Medicine. Speaker Disclosure: Gynecologic Cancer Care in the Age of Precision Medicine Gynecologic Cancers in the Age of Precision Medicine Advances in Internal Medicine Lee-may Chen, MD Department of Obstetrics, Gynecology & Reproductive

More information

Endometriosis. What you need to know. 139 Dumaresq Street Campbelltown Phone Fax

Endometriosis. What you need to know. 139 Dumaresq Street Campbelltown Phone Fax Endometriosis What you need to know 139 Dumaresq Street Campbelltown Phone 4628 5292 Fax 4628 0349 www.nureva.com.au September 2015 What is Endometriosis? Endometriosis is a condition whereby the lining

More information

2 Philomeen Weijenborg, Moniek ter Kuile and Frank Willem Jansen.

2 Philomeen Weijenborg, Moniek ter Kuile and Frank Willem Jansen. Adapted from Fertil Steril 2007;87:373-80 Intraobserver and interobserver reliability of videotaped laparoscopy evaluations for endometriosis and adhesions 2 Philomeen Weijenborg, Moniek ter Kuile and

More information

Gynecologic Cancers are many diseases. Speaker Disclosure: Gynecologic Cancer Care in the Age of Precision Medicine. Controversies in Women s Health

Gynecologic Cancers are many diseases. Speaker Disclosure: Gynecologic Cancer Care in the Age of Precision Medicine. Controversies in Women s Health Gynecologic Cancer Care in the Age of Precision Medicine Gynecologic Cancers in the Age of Precision Medicine Controversies in Women s Health Lee-may Chen, MD Department of Obstetrics, Gynecology & Reproductive

More information

One Thousand Cases of Infertility

One Thousand Cases of Infertility One Thousand Cases of Infertility Clinical Review of a Five-Year Series Robert B. Wilson, M.D. THE RECORDS of 1032 women who complained of infertility have been reviewed. These patients were seen by various

More information